Allspring Global Investments Holdings LLC boosted its stake in Chemed Co. (NYSE:CHE – Free Report) by 9.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,052 shares of the company’s stock after buying an additional 3,785 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Chemed were worth $24,314,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CHE. UMB Bank n.a. grew its holdings in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Trust Co. of Vermont bought a new stake in Chemed during the fourth quarter worth about $34,000. Farther Finance Advisors LLC increased its holdings in shares of Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares in the last quarter. KBC Group NV raised its stake in shares of Chemed by 11.5% in the third quarter. KBC Group NV now owns 378 shares of the company’s stock valued at $227,000 after acquiring an additional 39 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in shares of Chemed by 59.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 425 shares of the company’s stock worth $255,000 after acquiring an additional 159 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Insider Activity at Chemed
In other Chemed news, VP Brian C. Judkins bought 145 shares of Chemed stock in a transaction dated Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.
Chemed Price Performance
Chemed Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.36%. Chemed’s dividend payout ratio (DPR) is presently 10.11%.
Analysts Set New Price Targets
Several equities analysts have issued reports on the company. Royal Bank of Canada cut their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.
Read Our Latest Research Report on CHE
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
- Five stocks we like better than Chemed
- Options Trading – Understanding Strike Price
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Where Do I Find 52-Week Highs and Lows?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.